Page last updated: 2024-11-05

ticlopidine and Sclerosis, Systemic

ticlopidine has been researched along with Sclerosis, Systemic in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ntelis, K1
Gkizas, V1
Filippopoulou, A1
Davlouros, P1
Alexopoulos, D1
Andonopoulos, AP1
Daoussis, D1

Trials

1 trial available for ticlopidine and Sclerosis, Systemic

ArticleYear
Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study.
    BMC musculoskeletal disorders, 2016, 05-17, Volume: 17

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Animals; Clopidogrel; Endothelium, Vascular;

2016